Venetoclax
ADVERTISEMENT
- Molecular formula
- C45H50ClN7O7
- CAS Number
- 1257044-40-8
- IUPAC Name
- N-[3-chloro-2-[[methyl-(2-morpholino-2-oxo-ethyl)amino]methyl]phenyl]benzamide
- Molecular Weight
- 868.44g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2000g/cm3
- Synonyms
- FOMINOBEN
Identification
Interesting facts
Interesting Facts about N-[3-chloro-2-[[methyl-(2-morpholino-2-oxo-ethyl)amino]methyl]phenyl]benzamide
N-[3-chloro-2-[[methyl-(2-morpholino-2-oxo-ethyl)amino]methyl]phenyl]benzamide is a fascinating chemical compound with a highly intricate structure, showcasing the complexity and diversity of modern medicinal chemistry. Here are some intriguing insights about this compound:
- Structural Composition: The compound features a unique combination of a benzamide moiety with a morpholino and chloro substituent, which can significantly influence its biological activity.
- Pharmaceutical Relevance: Compounds like this are often studied for their potential therapeutic effects, particularly in areas such as oncology and infectious diseases, due to their ability to interact with specific biological targets.
- Complex Interactions: The morpholino group is known for its role in enhancing cellular uptake of the compound, potentially increasing its efficacy in drug delivery systems.
- Effects of Substituents: The presence of the chloro group can affect pharmacokinetics and pharmacodynamics, making this compound a candidate for structure-activity relationship (SAR) studies.
- Future Research: Ongoing research may focus on elucidating how variations in the chemical structure could lead to improved potency or reduced side effects, which is a common objective in drug design and development.
In conclusion, N-[3-chloro-2-[[methyl-(2-morpholino-2-oxo-ethyl)amino]methyl]phenyl]benzamide exemplifies the challenges and opportunities present in the field of chemistry. As scientists continue to explore such complex molecules, they uncover new dimensions of therapeutic potential and chemical behavior.